Durvalumab vs Escitalopram

## Durvalumab vs Escitalopram: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Escitalopram**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Escitalopram**: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Escitalopram — 27-32 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Escitalopram — C20H21FN2O.

**Molecular Weight**: Durvalumab — N/A; Escitalopram — 324.3920 g/mol.

**Type**: Durvalumab — Antibody; Escitalopram — Small molecule.